Jan Oscarsson
AstraZeneca (Netherlands)(NL)AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Growth Hormone and Insulin-like Growth Factors, Diabetes Treatment and Management, Liver Disease Diagnosis and Treatment, Metabolism, Diabetes, and Cancer, Lipid metabolism and disorders
Most-Cited Works
- → Peripheral Infusion of IGF-I Selectively Induces Neurogenesis in the Adult Rat Hippocampus(2000)848 cited
- → Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice(2012)603 cited
- → Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study(2018)379 cited
- → Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study(2021)303 cited
- → Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet(2010)292 cited
- → Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism(2007)